merck glp-1 agonist Design and discovery of a highly potent ultralong-acting and glucagon co-agonist for attenuating renal fibrosis Transforming obesity: The advancement of

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Lipo C does not directly enhance tirzepatide's efficacy, but concurrent use may support energy metabolism during caloric restriction

There is also concern about the potential stimulation of pre-existing testicular tumors with HCG treatment

An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease

Additional clinical trials are ongoing to validate its safety and long-term advantages